RP
Ravi Praksh Sharma
About Ravi Praksh Sharma
Data last updated:
Ravi Praksh Sharma is a Director at Relife Drugs Private Limited (since 2005) and Director at Almeda Lifesciences Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Relife Drugs Private Limited at ₹1.55 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Relife Drugs Private Limited U51397UP2005PTC030071 | Director | 30 May 2005 | 2005 | ₹1.55 Cr (FY 2025) | Active |
| Almeda Lifesciences Private Limited U46497DL2023PTC420218 | Director | 17 Sep 2023 | 2023 | Active |
Board colleagues of Ravi Praksh Sharma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Asif Ikbal Khan | 01420441 | Relife Drugs Private Limited | Director |
| Madhuri Sharma | 02526417 | Relife Drugs Private Limited | Director |
| Shubha Wati Sharma | 10325403 | Almeda Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Praksh Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Praksh Sharma
Ravi Praksh Sharma currently holds 2 directorships: Relife Drugs Private Limited (Director, since 30 May 2005, revenue ₹1.55 Cr (FY 2025)); Almeda Lifesciences Private Limited (Director, since 17 Sep 2023).
Ravi Praksh Sharma was first appointed on 30 May 2005 as Director at Relife Drugs Private Limited. The most recent appointment on record is 17 Sep 2023 at Almeda Lifesciences Private Limited.
The current boards of Ravi Praksh Sharma's companies include Asif Ikbal Khan (Relife Drugs Private Limited), Madhuri Sharma (Relife Drugs Private Limited), Shubha Wati Sharma (Almeda Lifesciences Private Limited).